Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China
Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, is sponsoring the Endpoints ASCO22 "Accelerating clinical...
Novotech Sponsors Pre-ASCO China Summit Expert Panels on Early Phase Oncology Trials and Regulatory...
Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, has sponsored expert panels at the Pre-ASCO...
Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials
Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its CRO services to the US, is pleased to sponsor the Pre-ASCO...
Novotech Acquires US CRO NCGS, Expands Global Expertise
Novotech, the leading Asia-Pacific biotech specialist CRO, has acquired US CRO NCGS as part of its expansion program, and can now offer its biotech...
Avance Clinical Finalist for Informa Pharma Intelligence Awards 2022 – Best Contract Research Organization...
Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has been selected as a finalist for the Best Contract Research...
Avance Clinical Announces New Office Opening in Melbourne
Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has opened new offices in Melbourne to support its growing clinical...
Avance Clinical Announces New Office Opening in Sydney
Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has opened new offices in Sydney to support its growing clinical...
Therapeutic Goods Administration of Australia Authorizes Moderna’s Covid-19 Vaccine in Children (6-11 Years)
Moderna, Inc., (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in Australia has...
Moderna Announces Plan to Expand Footprint in Asia with Four Additional Subsidiaries
Announcement reinforces Moderna's commitment to Asia and vision as a global commercial enterprise
New subsidiaries to be established in Malaysia, Taiwan, Singapore, and...
Novotech Recognized as Top 10 CRO in CenterWatch Site Relationship Benchmarking Report
Novotech, the leading Asia Pacific biotech specialist CRO, has been recognized as a top 10 CRO in the 2021 CenterWatch Global Site Relationship Benchmark...
Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022
Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has secured a significant investment from global private equity firm, The...
Apollomics Inc. To Host Virtual Investor Events on Wednesday, January 26, 2022 and Thursday,...
Apollomics Inc. an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced that the management team...
Apollomics Inc. Announces CEO Guo-Liang Yu, PhD Appointed as Chairman of the Board for...
Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced that Guo-Liang Yu, PhD,...
Apollomics Inc. Doses First Patient in Phase 3 Clinical Trial with APL-106 (Uproleselan Injection)...
Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced that the first patient...
Olympus Launches Venture Capital Fund to Strengthen Medtech Leadership
Initial fund targets medical devices, digital solutions, and diagnostics
Olympus Corporation (Tokyo: 7733), a global leader in medical technology, has announced the establishment of...
Agilex Biolabs Shares How to Select the Right Bioanalytical Tools for Immuno-oncology and Vaccines...
Agilex Biolabs, the Australian regulated bioanalytical and toxicology laboratory facilities for clinical trials is presenting a new webinar entitled "Getting it right! Considerations for...
Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting...
Avance Clinical, the largest premium Australian CRO for international biotechs, is pleased to share the news that its client XWPharma Ltd. has announced dosing...
Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox
The company is raising USD$25 million from investors in Australia, Asia and USA.
Topelia Australia, a biotech company established to commercialise a novel ATT treatment...
Agilex Biolabs Announced as Citeline Award Finalist for COVID-19 Vaccine Toxicology Preclinical Research
Agilex Biolabs, Australia's most experienced and technologically advanced bioanalytical laboratory and the only biolab in the region with a dedicated toxicology unit, has been...
Olympus Strengthens Surgical Portfolio with the Launch of POWERSEAL Advanced Bipolar Surgical Energy Devices
POWERSEAL Family of Devices Completes the Olympus Energy Portfolio, Offers Physicians Improved Performance and Ergonomics
Olympus Corporation (Representative Executive Officer, President and CEO: Yasuo...
